AL-LAD Facts
Psychedelic;
Description
AL-LAD (N6-allyl-6-norlysergic acid diethylamide) is a synthetic psychedelic of the lysergamide class. It activates serotonin receptors in the brain, producing the visual and cognitive shifts characteristic of classical psychedelics.[1]
Subjective effects include geometric visual patterns, brightened colors, time alteration, thought acceleration, and mood elevation.[2] The experience is often described as a gentler version of LSD — visually rich and stimulating, but with a softer onset and less demanding peak.
AL-LAD produces no physical dependence, and no lethal dose has been established in any species.[3] The primary risk is psychological — anxiety, panic, or psychosis in predisposed individuals — and tolerance builds so fast that compulsive use is self-limiting.[4]
Dose and durationby route · individual sensitivity varies
Starts in 20 – 60 minLasts 7 – 10 hoursAfter-effects 2 – 18 hours
Body and dependence
- Acute toxicity
- Negligible
- Chronic toxicity
- Negligible
- Physical dependence
- None
- Psychological dependence
- Negligible
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- Rapid
- Fully resets after
- 14 days
- Carries over to
- LSD;
psilocybin; mescaline; DMT
Effectslikely at a common dose
- Perception
- Color enhancement;
Visual drifting; Color alteration; Auditory enhancement; Music enhancement; Environmental patterning; Geometry; Visual breathing; Visual morphing; +25 possible, including Spatial disorientation, Visual haze / noise, Vestibular distortion - Body
- Wakefulness;
Pupil dilation; Spontaneous body sensations; Stimulation; Body high; +29 possible, including Insomnia, Muscle tension, Dizziness - Thinking
- Pattern recognition enhancement;
Cognitive euphoria; Novelty enhancement; Aesthetic enhancement; Introspection enhancement; +27 possible, including Suggestibility enhancement, Memory suppression, Thought loops - Feeling
- Emotional enhancement;
Euphoria; +6 possible, including Emotional lability, Anxiety, Paranoia - Self
- none likely · 10 possible, including Derealization, Depersonalization, Communication suppression
- Time
- Time alteration;
+4 possible, including Temporal disorientation - Transpersonal
- none likely · 1 possible
- Awareness
- none likely · 4 possible
Who shouldn't take it
Combinations60 recorded
Seek help immediately if
Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:
- Very high body temperature; hot, dry skin
- Seizures
- Chest pain; fast or irregular heartbeat
- Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
- Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
- Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm
What to do
- Stay calm and reassure — remind them they took a drug and the effect will pass
- Move to a calm, quiet, safe space with low light; reduce noise and sensory input
- Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
- Talk them down gently; don't grab or restrain unless they're in danger
- For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
- If overheating, cool the body; be ready to give rescue breaths / CPR
The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Brandt SD, Kavanagh PV, Westphal F, Stratford A, Elliott SP, Hoang K, Wallach J, Halberstadt AL (2016) Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD) — Drug Testing and Analysis doi:10.1002/dta.1884
- [2]^Coney LD, Maier LJ, Ferris JA, Winstock AR, Barratt MJ (2017) Genie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile — Human Psychopharmacology doi:10.1002/hup.2599
- [3]
- [4]^de la Fuente Revenga M, Jaster AM, McGinn J, Silva G, Saha S, Gonzalez-Maeso J (2022) Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice — ACS Chemical Neuroscience doi:10.1021/acschemneuro.2c00170